Skip to main content
. 2020 Aug 27;12(9):813. doi: 10.3390/pharmaceutics12090813

Table 2.

General characteristics; the characteristics of patients were simply classified. There were no significant differences between the two groups. Of the initial 49 patients, 11 were excluded, and the remaining 38 patients participated in the study.

Characteristics Categories Exp. (n = 19) Cont. (n = 19) t or x2 p
M ± SD/n (%) M ± SD/n (%)
Gender Male 10 (52.6) 12 (63.2) 0.43 0.511
Female 9 (47.4) 7 (36.8)
Age (years) 60.95 ± 12.40 60.63 ± 21.38 0.56 0.956
Period of prevalence (months) 9.26 ± 12.17 5.68 ± 3.19 1.19 0.248
Location of pressure sore Coccyx 12 (63.2) 14 (73.7) 3.82 0.431
Ischium 2 (10.5) 4 (21.1)
Trochanter 3 (15.8) 1 (5.3)
others 2 (10.6) 0 (0)
Stage of pressure sore Stage 3 1 (5.3) 0 (0) 1.03 0.311
Stage 4 18 (94.7) 19 (100)
Risk factors Age over 65 11 (57.9) 10 (52.6) 0.11 0.744
BMI (kg/m2) 19.55 (4.2) 20.38 (4.6) 0.58 0.570
Spinal cord injury 7 (36.8) 5 (26.3) 0.49 0.485
Brain damage 8 (42.1) 10 (52.6) 0.42 0.516
Acute phase disease 16 (84.2) 15 (78.9) 0.18 0.656
DM 7 (36.8) 4 (21.1) 1.15 0.283
ICU admission 5 (26.3) 5 (26.3) 0.00 1.000

n = 38; Cont. = Control group; Exp. = Experimental group; M = Mean; SD = Standard deviation.